Massive Seven-Million-Person Study Maps Metabolic Heart Risks Across the Lifespan

One of the largest prospective cohort studies ever conducted has revealed how six major metabolic risk factors shape cardiovascular disease risk differently at every stage of adult life. Drawing on longitudinal health records from more than 7.5 million adults in northwestern China, researchers have produced the first comprehensive, population-based map of metabolic burden and its cardiovascular consequences spanning the entire adult lifespan, from 18-year-olds to people in their nineties. The findings, published in The Lancet Regional Health – Western Pacific, suggest that early and middle adulthood represent a critically underused window for preventing heart attacks and strokes.

The study, known as the Tianshan Community Cohort, enrolled participants between January 2019 and December 2023 through 12,520 primary healthcare institutions across the Xinjiang Uyghur Autonomous Region, a territory of roughly 1.66 million square kilometers. The cohort is ethnically diverse, comprising approximately 53 percent Uyghur, 33 percent Han, and 14 percent other minority participants, with 52 percent women. Annual health examinations mandated by China’s National Basic Public Health Services Program provided repeated measurements of six metabolic risk factors: obesity, hepatic steatosis, hypertension, hyperlipidemia, diabetes, and renal dysfunction. Cardiovascular events were objectively ascertained from inpatient records at 163 tertiary hospitals and 63 traditional Chinese medicine hospitals, coded according to the tenth revision of the International Classification of Diseases.

Among the 7,513,828 participants included in the primary analysis, who had a mean age of 44.4 years, the researchers tracked 669,995 incident cardiovascular events over a median follow-up of 4.5 years, including 442,120 cases of coronary heart disease and 398,300 strokes. As expected, cardiovascular incidence rose steeply with age, from 1.8 per 1,000 person-years in adults under 40 to 107.5 per 1,000 person-years among the very old. But the striking discovery was not the raw incidence; it was how the strength of the link between each metabolic abnormality and cardiovascular risk transformed across the age spectrum, with a rigor that had never before been achieved at this scale.

The central message is that metabolic abnormalities exert their most potent cardiovascular effects in young adults, and the strength of these associations steadily attenuates with advancing age. Hypertension showed the most dramatic pattern: in adults under 40, it was associated with a 3.60-fold increase in cardiovascular risk, but in those aged 80 and older, the hazard ratio fell to just 1.21. Diabetes showed a similar attenuation, from a hazard ratio of 2.48 in the youngest group to 1.31 in the oldest, as did hyperlipidemia, which fell from 1.65 to 1.05, and renal dysfunction, from 1.69 to 1.12. Notably, hypertension in young adults carried an exceptionally strong association with stroke specifically, with a hazard ratio of 4.84. When multiple metabolic abnormalities coexisted, the risk compounded: young adults with three or more risk factors had a 3.16-fold higher cardiovascular risk compared with metabolically healthy peers, whereas the excess risk among the very old with equivalent multimorbidity was only 1.50-fold.

The study also uncovered a striking age-dependent sexual dimorphism in metabolic health. In young adulthood, women enjoyed a clear metabolic advantage, being more likely to be metabolically normal and less likely to carry three or more simultaneous metabolic abnormalities. However, this female advantage reversed around age 45, when women became less likely to be metabolically normal than men, and a second reversal occurred around age 50, when the prevalence of multimorbidity in women surpassed that of men. The underlying factors crossed over at different ages: obesity and hepatic steatosis became more prevalent in women around age 40, hypertension around 50, and hyperlipidemia around 55. The researchers suggest that reproductive transitions, pregnancy-related hormonal shifts, childrearing-related lifestyle changes, and the perimenopausal reshaping of body composition likely drive this midlife reversal, making women a uniquely vulnerable population during this period.

Sex also mattered for the strength of metabolic risk itself. In adults under 40, hypertension was associated with a stronger cardiovascular impact in women than in men, with a hazard ratio for stroke of 6.41 in young women compared with 4.22 in young men, a clinically meaningful disparity that the researchers flagged using a predefined ratio-of-hazard-ratios threshold. Conversely, renal dysfunction carried a stronger cardiovascular penalty for men than women in the two youngest age groups. These sex-specific patterns largely faded in older groups, suggesting that the physiological vulnerability of young women to hypertension-related vascular damage has been substantially underappreciated in a literature dominated by middle-aged and elderly cohorts.

To translate individual risk into population impact, the team calculated population attributable fractions, the proportion of cardiovascular disease cases that could be attributed to each metabolic factor, using a method that permutes each risk factor through every possible position in the statistical hierarchy to account for correlations and shared causal pathways. The combined metabolic burden showed an inverted U-shaped pattern across the lifespan, peaking in midlife at 37.89 percent among adults aged 40 to under 60, compared with 29.78 percent in young adults, 25.24 percent in those aged 60 to 80, and 15.85 percent in the very old. Obesity was the single largest contributor to cardiovascular burden in every age group, potentially explaining between 6.07 and 11.86 percent of incident cardiovascular cases across adulthood, followed by hypertension and hepatic steatosis. For coronary heart disease, obesity’s attributable fraction reached 13.91 percent in the middle-aged group, while for stroke, hypertension was the predominant contributor at every age. The researchers attribute obesity’s outsized regional prevalence partly to northwestern China’s distinctive climate, ethnic composition, and dietary habits, and they argue that its dual role as an upstream driver of other metabolic disorders makes obesity prevention the most consequential public health lever available.

Perhaps the most actionable finding came from analyzing what happens when metabolically abnormal people change their metabolic state. Among 3,712,053 participants with at least one metabolic risk factor at baseline, the researchers tracked transitions between the first and second health examinations, separated by a median of roughly one year. The results showed a clear dose-response relationship: each additional risk factor gained increased cardiovascular risk, and each one lost decreased it. Critically, the benefit of improvement was strongly age-dependent. Young adults who brought three or more metabolic risk factors under control within about a year experienced a 55 percent lower subsequent cardiovascular risk, compared with only a 17 percent reduction among the very old. The authors interpret this asymmetry through the lens of disease biology: metabolic derangements in the young are typically nascent and largely reversible, with minimal cumulative end-organ damage, whereas in the very old, metabolic control often represents long-term maintenance rather than true reversal, frequently accompanied by multimorbidity and polypharmacy.

The time-series analysis of 1,649,758 participants with five consecutive annual examinations added an alarming temporal dimension. In the youngest age group, obesity prevalence climbed from 36.0 percent in 2019 to 48.5 percent in 2023, while the proportion of metabolically normal individuals fell from 50.9 percent to 38.8 percent in just five years, a pace of deterioration far exceeding that seen in older groups. The authors note that metabolic abnormalities in young adults are chronically under-recognized and under-treated, and that without prompt intervention these abnormalities can progress into a self-reinforcing vicious cycle of insulin resistance and inflammation. In a region where cardiovascular disease causes an estimated 19.2 million deaths and 437 million disability-adjusted life years globally each year, and where 42 percent of incident cardiovascular cases in China are attributable to four major metabolic risk factors, the implications are stark.

Taken together, the study argues for a fundamental reallocation of preventive attention toward people under 60, and particularly toward young adults, who have been almost entirely absent from the evidence base that shapes current guidelines. Despite the persistently high metabolic burden in older adults, the window of maximal cardiovascular benefit from metabolic management appears confined to early and middle adulthood. The findings also call for age-specific and gender-sensitive strategies: intensified screening for hypertension in young women, obesity control as the universal top priority, and vigilant monitoring of midlife women as their metabolic advantage erodes through reproductive and menopausal transitions. The researchers acknowledge limitations, including the use of an indirect index rather than imaging to define hepatic steatosis, the absence of systematic medication data, self-reported lifestyle covariates, and the relatively short five-year follow-up, but extensive sensitivity analyses, including competing-risk regression, landmark analyses, and multiple imputation, consistently supported the primary conclusions. As the dual epidemics of youthful metabolic deterioration and population aging accelerate, this unprecedented cohort provides both a warning and a roadmap: the earlier metabolic health is restored, the greater the lifetime cardiovascular dividend.

Subject of Research: Metabolic risk factors and their age- and sex-specific impact on cardiovascular disease across the adult lifespan

Article Title: A landscape of metabolic burden and its cardiovascular impact across the adult lifespan: a prospective cohort study of 7.5 million people in Northwestern China

Article References: Liu, Z.-Y., Yang, J., Lyu, J.-Q., Miao, M.-Y., Qin, L.-Q., Wang, H.-P., Wan, Z., Huang, Q., Tao, J., Yang, Y., Di, Q., Yang, Y., Gu, K., & Chen, G.-C. (2026). A landscape of metabolic burden and its cardiovascular impact across the adult lifespan: a prospective cohort study of 7.5 million people in Northwestern China. The Lancet Regional Health – Western Pacific, 74, Article 101986. https://doi.org/10.1016/j.lanwpc.2026.101986

Image Credits: AI Generated

DOI: 10.1016/j.lanwpc.2026.101986

Keywords: cardiovascular disease, metabolic risk factors, obesity, hypertension, diabetes, hepatic steatosis, renal dysfunction, population attributable fraction, young adults, sex differences, prospective cohort, China